Dihydroorotate Dehydrogenase Inhibitor, Brequinar
CAS: 96201-88-6
Ref. 3D-WDA20188
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Monday 1 Jul 2024
Product Information
Name:
Dihydroorotate Dehydrogenase Inhibitor, Brequinar
Synonyms:
- Brequinar sodium
- Nsc-368390
- DuP-785
- Sodium 6-Fluoro-2-(2'-Fluorobiphenyl-4-Yl)-3-Methylquinoline-4-Carboxylate
CAS:
Description:
Brequinar is a dihydroorotate dehydrogenase inhibitor that has been shown to inhibit the mitochondrial function and replication of DNA. The drug is used in combination therapy with other agents, such as uridine, for the treatment of colon cancer. Brequinar works by inhibiting the formation of dihydroorotate, which is an intermediate in pyrimidine synthesis. It also has immunosuppressive properties and can be used for the treatment of autoimmune diseases.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
397.35 g/mol
Formula:
C23H14F2NNaO2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: 3D-WDA20188 Dihydroorotate Dehydrogenase Inhibitor, Brequinar
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
